UOXFi006-A

OX2-28

iPSC line

At European Collection of Authenticated Cell Cultures (ECACC)
A CLIP contains information about a cell line including any specific third party obligations relating to, for example, licensing obligations or the donor consent which affect the use of the cell line.
A batch specific Certificate of Analysis will be available to download once you receive your EBiSC iPSC line.

General#

Cell Line

hPSCreg Name UOXFi006-A
Alternative name(s)
OX2-28
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
UKKi011-A
(NP0040-8)
UKKi012-A
(NP0041-17, NP0041)
UKBi002-A
(iLB-C2-36m-r2)
UKBi004-A
(LB-30-12, iLB-C1-30m-r12)
UKBi006-A
(iLB-C-35m-r1, LB-35-1)
RBi001-A
(fb101, RB101)
HUBi001-A
(HUB001Ai)
UOXFi005-A
(JR053-1, SAMEA4453899)
UKKi020-A
(NP0100-4)
UKKi021-A
(NP0105-2)
UKKi020-B
(NP0100-8)
UKKi021-B
(NP0105-19)
UKKi020-C
(NP0100-10E)
UKKi020-D
(NP0100-11)
UKBi005-A
(iLB-C-31f-r1, LB-31-1)
EDi002-A
(NAS2)
UNEWi021-A
(F018 13.2)
Donor's gene variants:
CFH
Donor diseases:
age-related macular degeneration
UNEWi021-B
(F018 15.8)
Donor's gene variants:
CFH
Donor diseases:
age-related macular degeneration
UNEWi021-C
(F018 17/8-1)
Donor's gene variants:
CFH
Donor diseases:
age-related macular degeneration
UNEWi023-A
(F343 clone 2)
Donor's gene variants:
CFH
Donor diseases:
age-related macular degeneration
UNEWi025-A
(F324 5.8)
Donor's gene variants:
CFH
Donor diseases:
age-related macular degeneration
UNEWi023-B
(F343 clone 3)
Donor's gene variants:
CFH
Donor diseases:
age-related macular degeneration
UNEWi023-C
(F343 clone 4)
Donor's gene variants:
CFH
Donor diseases:
age-related macular degeneration
UNEWi025-B
(F324 12.8)
Donor's gene variants:
CFH
Donor diseases:
age-related macular degeneration
UNEWi025-C
(F324 19.7)
Donor's gene variants:
CFH
Donor diseases:
age-related macular degeneration
UKKi022-A
(NP0106-34)
BIONi037-A
(16423 ApoE3/3 (control line))
UKKi022-C
(NP0106-10A)
UKKi022-D
(NP0106-5)
UKKi008-A
(NP0016-3)
Donor's gene variants:
SCN5A
Donor diseases:
Prolonged QT interval
UNEWi004-A
(PRPF31 SH)
Donor's gene variants:
PRPF31
Donor diseases:
Retinitis pigmentosa
UNEWi005-A
(PRPF31 RH)
Donor's gene variants:
PRPF31
Donor diseases:
Retinitis pigmentosa
UKBi003-A
(iLB-MJD1-32m-r9, LB-32-r9)
Donor's gene variants:
ATXN3, ATXN3
Donor diseases:
Spinocerebellar ataxia type 3
UKBi008-A
(iLB-MJD4-34m-r1, LB-34-1)
Donor's gene variants:
ATXN3, ATXN3
Donor diseases:
Spinocerebellar ataxia type 3
WTSIi002-A
(HPSI0913i-eika_2)
WTSIi004-A
(HPSI1113i-qolg_3)
WTSIi006-A
(HPSI1113i-hayt_1)
WTSIi008-A
(HPSI1013i-kuxp_1)
WTSIi010-A
(HPSI0314i-xugn_1)
WTSIi013-A
(HPSI0214i-kucg_2)
WTSIi014-A
(HPSI0214i-heja_2)
WTSIi016-A
(HPSI0114i-oevr_3)
WTSIi018-A
(HPSI0114i-kolf_3)
WTSIi019-A
(HPSI0114i-iisa_3)
BIONi010-A
(K1P53)
BIONi010-B
(K2P53, BIONi010-B)
BIONi010-C
(BIONi010-C, K3P53)
WTSIi022-A
(HPSI1013i-yemz_1)
WTSIi023-A
(HPSI0114i-zapk_3)
WTSIi025-A
(HPSI1013i-pamv_1)

Provider

Depositor University of Oxford (UOXF)
Distributors
EBiSC
European Collection of Authenticated Cell Cultures (ECACC)

External Databases

hPSCreg UOXFi006-A
BioSamples SAMEA4458551
Cellosaurus CVCL_IJ09
ECACC 66540398
CLO CLO_0100930
Wikidata Q54991449

General Information

* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: not allowed
Commercial use: not allowed

Donor Information#

General Donor Information

Sex male
Age of donor (at collection) 40-44

Phenotype and Disease related information (Donor)

Diseases No disease was diagnosed.

Karyotyping (Donor)

Has the donor karyotype been analysed?
Unknown

External Databases (Donor)

BioSamples SAMEA4458550

hIPSC Derivation#

General

Source cell type
fibroblast of dermis
Source cell origin
zone of skin
Any portion of the organ that covers that body and consists of a layer of epidermis and a layer of dermis.
Age of donor (at collection) 40-44
Collected in 2010
Passage number reprogrammed 2

Reprogramming method

Vector type Integrating
Vector Virus (Retrovirus)
Genes
Is the used vector excisable?
No
Absence of reprogramming vector(s)?
Yes
Reprogramming vectors silenced?
Yes
Methods used
RT-PCR

Vector free reprogramming

Other

Selection criteria for clones Morphology
Derived under xeno-free conditions
No
Derived under GMP?
No
Available as clinical grade?
No

Culture Conditions#

Latest released batch

Culture medium mTeSR
Passage method EDTA
Surface coating Matrigel / Geltrex
O2 concentration 20
CO2 concentration 5
Temperature 37
The following are the depositor culture conditions, they do not refer to any specific batch.
Surface coating Matrigel/Geltrex
Feeder cells
No
Passage method Enzyme-free cell dissociation
EDTA
O2 Concentration 20 %
CO2 Concentration 5 %
Medium mTeSR™ 1

Characterisation#

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR FACS Enzymatic Assay Expression Profiles
TRA 1-60
Yes
NANOG
Yes
SSEA-4
Yes
SSEA-1
No
Pluripotency Score Novelty Score
22.22 1.75

Microbiology / Virus Screening

HIV 1 Negative
HIV 2 Negative
Hepatitis B Negative
Hepatitis C Negative
Mycoplasma Negative

Sterility

Inoculation for microbiological growth No Contaminants Detected
Mycoplasma Not Detected
Viability Viable post-cryopreservation

Genotyping#

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
46, XY
Passage number: 12
Karyotyping method: CytoSNP-12v2.1 bead chip array

Other Genotyping (Cell Line)